ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ENVB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/04	07:58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ENVB	Enveric Biosciences Inc
2024/06/04	07:58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/30	21:00	Business Wire	Enveric Biosciences to Participate in BIO International Convention 2024	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/30	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/23	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/18	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/15	19:00	Business Wire	Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/14	21:00	Business Wire	Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders	NASDAQ:ENVB	Enveric Biosciences Inc
2024/05/08	20:00	Business Wire	Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids	NASDAQ:ENVB	Enveric Biosciences Inc
2024/03/26	20:00	Business Wire	Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023	NASDAQ:ENVB	Enveric Biosciences Inc
2024/03/19	20:00	Business Wire	Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	NASDAQ:ENVB	Enveric Biosciences Inc
2024/03/12	20:00	Business Wire	Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets	NASDAQ:ENVB	Enveric Biosciences Inc
2024/03/12	01:35	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ENVB	Enveric Biosciences Inc
2024/03/11	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/29	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/29	21:00	Business Wire	Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/27	06:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/27	06:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/27	06:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/23	22:00	Business Wire	Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/21	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/21	22:00	Business Wire	Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/15	05:36	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/09	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/07	00:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ENVB	Enveric Biosciences Inc
2024/02/06	07:09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ENVB	Enveric Biosciences Inc
2024/01/24	22:05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ENVB	Enveric Biosciences Inc
2024/01/23	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ENVB	Enveric Biosciences Inc
2024/01/12	06:43	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ENVB	Enveric Biosciences Inc
2024/01/09	06:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENVB	Enveric Biosciences Inc